Berita

NYC-Based Excelsior Sciences Looks to Blur Boundary Bet...

The New York-based company enables AI-guided optimization through a molecule’s l...

Additive Manufacturing as a Flexible Option for Bespoke...

Additive manufacturing, also known as 3D printing, has potential advantages over...

Manufacturing Science Matters in Biosimilar Retinal Bio...

The surge of retinal biosimilars highlights how manufacturing science shapes cos...

Biosynthesis of Medicarpin in Engineered Yeast

Yeast-based de novo synthesis of medicarpin, an antitumor & antibiotic isoflavon...

Cell Lines That Make Their Own Amino Acids

New Chinese Hamster Ovary (CHO) cell lines can manufacture additional amino acid...

21st Annual Nursing Hero Award

2026 – Celebrating Canada’s Nurses and Their Contributions! Along with having th...

21st Annual Nursing Hero Awards

Celebrating Canada’s Nurses and Their Contributions! Along with having their sto...

Microglia Activity in the Brain Drives Infantile Amnesi...

Immune cells in the brain may explain why infants across species fail to retain ...

Nasal Passage Cell Response to Common Cold Virus Determ...

Preclinical study demonstrates how the cells in our noses defend us from the com...

What’s the most-used emoji in medical records?

The use of emojis in medical records appears to be on the upswing, according to ...

GSK to Acquire Rapt for $2.2B, Adding Food Allergy Cand...

Ozureprubart is designed for every-12-week dosing, a less frequent dosage than t...

Key Strategies for dsRNA Control and Quantitation in Em...

As mRNA based therapeutics move beyond the early vaccine successes to encompass ...

Astellas Takes Aim at XLMTM Again, Now with MyoAAV Caps...

The therapy, which Kate calls KT430, is being developed by Astellas through an e...

NYC-Based Excelsior Looks to Blur Boundary Between Disc...

The New York-based company enables AI-guided optimization through a molecule’s l...

Dormant Cancer Cells Evade Immune System by Changing Sh...

Cancer cells that disseminate from a tumor can enter a period of dormancy that m...

StockWatch: Sarepta CEO Defends Elevidys as Q4 Sales Fa...

Sarepta Therapeutics saw its stock skid 11% after the company announced prelimin...